JPRN-UMIN000006914已完成未知
postmarketing surveillance For Investigating success in achieving clinical and functional Remission and Sustaining efficacy with Tocilizumab in BIOlogics naive RA patients - FIRST-BIO study
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 700
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •No criteria
研究者
相似试验
进行中（未招募）
1 期
Study To Evaluate The Safety And Efficacy Of Vfend® IV in Korean patientsEUCTR2017-000197-11-Outside-EU/EEAPfizer Inc.400
已完成
4 期
A post-marketing study of the marketed product Maxtra® P syrup for the evaluation of safety and effects in children having common cold.CTRI/2021/02/031189Zuventus Healthcare Limited200
已完成
4 期
A post-marketing study of the marketed product Maxtra® P Tablets for the evaluation of safety and effects in children having common cold.CTRI/2021/02/031390Zuventus Healthcare Limited200
进行中（未招募）
不适用
reactogenicity and safety of Vaxem™HibMeningitis, epiglottitis, pneumonia, arthritis caused by Haemophilus influenzae type b.EUCTR2014-005203-24-Outside-EU/EEAovartis Vaccines and Diagnostics750
进行中（未招募）
4 期
A post-marketing surveillance study to evaluate the safety and immunological response of typhoid conjugate vaccine in healthy subjectsCTRI/2021/11/037996Cadila Healthcare Limited